02 June 2009 09:23 [Source: ICIS news]
The acquisition had been finalised, DSM said, adding that the impact on its net sales in 2009 and 2010 was not expected to be material.
The company said the acquisition of privately held Biopract would serve as an entry point for DSM into the biogas market, which was showing 15-20% growth per year.
Founded in 1992, Biopract's main focus has been on the commercialisation and extension of its Methaplus enzyme series for the improvement of agricultural and industrial biogas production.
"We are convinced that biotechnology will contribute significantly to the sustainable and efficient use of natural resources today and in the future. We look forward to combining Biopract's expertise with ours to further increase the efficiency and performance of biogas plants," said Rob van Leen, chief innovation officer of DSM.
Biogas is produced by anaerobic fermentation of biodegradable materials such as biomass, manure or sewage, green waste and energy crops. It can be used to generate electricity and as a low-cost fuel for any heating purpose and can be upgraded to natural gas quality.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|